STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response by Sadrkhanloo, Mehrdokht, Entezari, Maliheh, Orouei, Sima, Ghollasi, Marzieh, fathi, Nikoo, Rezaei, Shamin, Hejazi, Elahe Sadat, Kakavand, Amirabbas, Saebfar, Hamidreza, Hashemi, Mehrdad, Goharrizi, Mohammad Ali Sheikh Beig, Salimimoghadam, Shokooh, Rashidi, Mohsen, Taheriazam, Afshin, Samarghandian, Saeed

Get full text

miRNAs as short non-coding RNAs in regulating doxorubicin resistance by Mirzaei, Sepideh, Paskeh, Mahshid Deldar Abad, Moghadam, Farhad Adhami, Entezari, Maliheh, Koohpar, Zeinab Khazaei, Hejazi, Elahe Sadat, Rezaei, Shamin, kakavand, Amirabbas, Aboutalebi, Maryam, Zandieh, Mohammad Arad, Rajabi, Romina, Salimimoghadam, Shokooh, Taheriazam, Afshin, Hashemi, Mehrdad, Samarghandian, Saeed

Get full text

LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions by Entezari, Maliheh, Taheriazam, Afshin, Orouei, Sima, Fallah, Shayan, Sanaei, Arezoo, Hejazi, Elahe Sadat, Kakavand, Amirabbas, Rezaei, Shamin, Heidari, Hajar, Behroozaghdam, Mitra, Daneshi, Salman, Salimimoghadam, Shokooh, Mirzaei, Sepideh, Hashemi, Mehrdad, Samarghandian, Saeed

Get full text

Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance by Hashemi, Mehrdad, Hajimazdarany, Shima, Mohan, Chakrabhavi Dhananjaya, Mohammadi, Maryam, Rezaei, Shamin, Olyaee, Yeganeh, Goldoost, Yeganeh, Ghorbani, Amin, Mirmazloomi, Seyed Reza, Gholinia, Nazanin, Kakavand, Amirabbas, Salimimoghadam, Shokooh, Ertas, Yavuz Nuri, Rangappa, Kanchugarakoppal S., Taheriazam, Afshin, Entezari, Maliheh

Get full text

SOX2 function in cancers: Association with growth, invasion, stemness and therapy response by Mirzaei, Sepideh, Paskeh, Mahshid Deldar Abad, Entezari, Maliheh, Mirmazloomi, Seyed reza, Hassanpoor, Aria, Aboutalebi, Maryam, Rezaei, Shamin, Hejazi, Elahe Sadat, Kakavand, Amirabbas, Heidari, Hajar, Salimimoghadam, Shokooh, Taheriazam, Afshin, Hashemi, Mehrdad, Samarghandian, Saeed

Get full text

Targeting PI3K/Akt signaling in prostate cancer therapy by Hashemi, Mehrdad, Taheriazam, Afshin, Daneii, Pouria, Hassanpour, Aria, kakavand, Amirabbas, Rezaei, Shamin, Hejazi, Elahe Sadat, Aboutalebi, Maryam, Gholamrezaie, Hamidreza, Saebfar, Hamidreza, Salimimoghadam, Shokooh, Mirzaei, Sepideh, Entezari, Maliheh, Samarghandian, Saeed

Get full text

Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies by Hashemi, Mehrdad, Zandieh, Mohammad Arad, Talebi, Yasmin, Rahmanian, Parham, Shafiee, Sareh Sadat, Nejad, Melina Maghsodlou, Babaei, Roghayeh, Sadi, Farzaneh Hasani, Rajabi, Romina, Abkenar, Zahra Oryan, Rezaei, Shamin, Ren, Jun, Nabavi, Noushin, Khorrami, Ramin, Rashidi, Mohsen, Hushmandi, Kiavash, Entezari, Maliheh, Taheriazam, Afshin

Get full text

The pharmacological and biological importance of EZH2 signaling in lung cancer by Entezari, Maliheh, Taheriazam, Afshin, Paskeh, Mahshid Deldar Abad, Sabouni, Eisa, Zandieh, Mohammad Arad, Aboutalebi, Maryam, Kakavand, Amirabbas, Rezaei, Shamin, Hejazi, Elahe Sadat, Saebfar, Hamidreza, Salimimoghadam, Shokooh, Mirzaei, Sepideh, Hashemi, Mehrdad, Samarghandian, Saeed

Get full text

siRNA and targeted delivery systems in breast cancer therapy by Mirzaei, Sepideh, Paskeh, Mahshid Deldar Abad, Entezari, Maliheh, Bidooki, Seyed Hesamoddin, Ghaleh, Vahideh Javadian, rezaei, Shamin, Hejazi, Elahe Sadat, Kakavand, Amirabbas, Behroozaghdam, Mitra, Movafagh, Abolfazl, Taheriazam, Afshin, Hashemi, Mehrdad, Samarghandian, Saeed

Get full text